Metraipolis › archive › dc_ca097c13ffb1

Long-term safety of Credelio Quattro™ (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets), a novel orally administered combination… — Europe PMC PMID:41398970

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41398970
DOI
10.1186/s13071-[numero omesso]-3
License (as archived)
solo-consultazione
Archived
2026-11-07T15:28:33.355Z
SHA-256 of the archived text
549a6ab24284411474d8ab8b1ce2083546e5eb154c5e8cedba03abc208da33d0
Stable URL of this page
https://metraipolis.com/documento/dc_ca097c13ffb1

How to cite

Long-term safety of Credelio Quattro™ (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets), a novel orally administered combination… — Europe PMC PMID:41398970 — Europe PMC (en), https://europepmc.org/article/MED/41398970 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ca097c13ffb1 (Metraipolis archive dc_ca097c13ffb1, sha256 549a6ab24284411474d8ab8b1ce2083546e5eb154c5e8cedba03abc208da33d0)
BibTeX
@misc{dcca097c13ffb1,
  title = {Long-term safety of Credelio Quattro™ (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets), a novel orally administered combination… — Europe PMC PMID:41398970},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41398970},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ca097c13ffb1; sha256 549a6ab24284411474d8ab8b1ce2083546e5eb154c5e8cedba03abc208da33d0},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41398970. Agents can read the archived copy with the MCP tool read_document.